Elaine Smith-Coustan

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Leukaemia Flow Cytometry in Yemen.

Leukaemia Flow Cytometry in Yemen.

Journal: International journal of laboratory hematology

Published: July 24, 2025

Fratricide-resistant CD7-CAR T cells in T-ALL.

Fratricide-resistant CD7-CAR T cells in T-ALL.

Journal: Nature medicine

Published: April 10, 2024

Closing the circle for ETP ALL.

Closing the circle for ETP ALL.

Journal: Blood

Published: December 14, 2023

Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia.

Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia.

Journal: Blood advances

Published: December 12, 2022

Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16.

Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16.

Journal: Blood advances

Published: July 14, 2022

High frequency of heat shock protein 27 overexpression is a highly effective, high-coverage marker for minimal residual disease detection in children with B-cell acute lymphoblastic leukemia.

High frequency of heat shock protein 27 overexpression is a highly effective, high-coverage marker for minimal residual disease detection in children with B-cell acute lymphoblastic leukemia.

Journal: Pediatric blood & cancer

Published: January 19, 2022

Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.

Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.

Journal: Blood cancer discovery

Published: July 12, 2021

Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.

Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.

Journal: Blood advances

Published: April 01, 2021

Reduced-intensity therapy for pediatric lymphoblastic leukemia: impact of residual disease early in remission induction.

Reduced-intensity therapy for pediatric lymphoblastic leukemia: impact of residual disease early in remission induction.

Journal: Blood

Published: July 14, 2020

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 26, 2020

Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.

Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.

Journal: Blood

Published: November 18, 2019

Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.

Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 29, 2019

Showing 1-12 of 37

Last Updated: 09/26/2026